Quest Diagnostics, Inc.

NYSE:DGX   3:59:51 PM EDT
149.89
-3.20 (-2.09%)
4:00:00 PM EDT: $149.95 +0.06 (+0.04%)
Other Pre-Announcement

Quest Diagnostics Updates Outlook For Full Year 2021

Published: 09/09/2021 11:13 GMT
Quest Diagnostics, Inc. (DGX) - Quest Diagnostics Updates Outlook for Full Year 2021.
Quest Diagnostics Inc - Revenues for Full Year 2021 Now Expected to Be $9.84-$10.09 Billion Compared to Previous Outlook of $9.54-$9.79 Billion.
Quest Diagnostics - Reported Diluted EPS for Full Year 2021 Now Expected to Be $12.54-$13.24 Compared to Previous Outlook of $11.48-$12.18.
Quest Diagnostics - Adjusted Diluted EPS for Full Year 2021 Now Expected to Be $11.65-$12.35 Compared to Previous Outlook of $10.65-$11.35.
Quest Diagnostics - Cash Provided by Operations for Full Year 2021 Now Expected to Be at Least $2 Billion Versus Previous Outlook of at Least $1.9 Billion.
Quest Diagnostics - Covid-19 Molecular Testing Volumes Were Stronger Than Anticipated Through End of August.
Quest Diagnostics - Low End of Co's Outlook Now Assumes Average Covid-19 Volumes of at Least 40,000 Molecular Tests per Day for H2 of Year.